Scarica l'app Stockscreener
1.32
1.54%
0.02
Pre-mercato:
1.33
0.01
+0.76%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché OPK Giù?
Forum
Previsione
Precedente Chiudi:
$1.30
Aprire:
$1.3
Volume 24 ore:
2.43M
Relative Volume:
0.79
Capitalizzazione di mercato:
$1.05B
Reddito:
$711.41M
Utile/perdita netta:
$-133.73M
Rapporto P/E:
-6.9474
EPS:
-0.19
Flusso di cassa netto:
$-199.99M
1 W Prestazione:
+4.76%
1M Prestazione:
-2.22%
6M Prestazione:
-19.51%
1 anno Prestazione:
-12.00%
Intervallo 1D:
$1.29
$1.34
Intervallo di 1 settimana:
$1.22
$1.34
Portata 52W:
$1.11
$2.035
Opko Health Inc Stock (OPK) Company Profile
Nome
Opko Health Inc
Settore
Industria
Telefono
305-575-4181
Indirizzo
4400 BISCAYNE BLVD., MIAMI, FL
Confronta OPK con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OPK
Opko Health Inc
|
1.32 | 1.03B | 711.41M | -133.73M | -199.99M | -0.19 |
|
TMO
Thermo Fisher Scientific Inc
|
477.41 | 174.60B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
205.72 | 143.04B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
652.27 | 52.17B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
117.32 | 32.42B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
185.91 | 30.62B | 15.50B | 1.33B | 2.16B | 7.34 |
Opko Health Inc Stock (OPK) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-25 | Iniziato | JP Morgan | Neutral |
| 2023-06-29 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2022-12-15 | Iniziato | H.C. Wainwright | Buy |
| 2022-01-24 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2021-06-21 | Iniziato | Ladenburg Thalmann | Buy |
| 2019-11-25 | Iniziato | Piper Jaffray | Overweight |
| 2018-03-02 | Downgrade | JP Morgan | Neutral → Underweight |
| 2017-09-14 | Downgrade | JP Morgan | Overweight → Neutral |
| 2016-06-21 | Reiterato | Standpoint Research | Buy |
| 2016-06-03 | Iniziato | Standpoint Research | Buy |
| 2016-03-31 | Reiterato | Barrington Research | Outperform |
| 2015-10-16 | Iniziato | JP Morgan | Overweight |
| 2015-09-11 | Downgrade | Jefferies | Buy → Hold |
| 2015-03-03 | Downgrade | Oppenheimer | Outperform → Perform |
| 2014-05-12 | Reiterato | Oppenheimer | Outperform |
| 2014-03-14 | Iniziato | Oppenheimer | Outperform |
| 2013-11-13 | Reiterato | Ladenburg Thalmann | Buy |
| 2013-05-30 | Reiterato | Ladenburg Thalmann | Buy |
| 2012-10-22 | Iniziato | Barrington Research | Outperform |
| 2011-12-01 | Reiterato | Ladenburg Thalmann | Buy |
| 2011-07-14 | Iniziato | Ladenburg Thalmann | Buy |
Mostra tutto
Opko Health Inc Borsa (OPK) Ultime notizie
OPKO Health, Inc. (NASDAQ:OPK) CEO Buys $891,000.00 in Stock - MarketBeat
OPKO Health’s (OPK) Oral GLP-2 Analog Selected for a Poster Presentation in Collaboration with Entera Bio (ENTX) - MSN
OPKO Health (NASDAQ:OPK) Shares Gap Up Following Insider Buying Activity - MarketBeat
Y.D. More Investments Ltd Has $2.97 Million Stock Holdings in OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat
Is OPKO Health Inc. affected by consumer sentimentBreakout Stocks with Huge Upside - newsyoung.net
Phillip Frost Spends US$891k On OPKO Health Stock - simplywall.st
Phillip Frost Buys Handful Of Shares In OPKO Health - Yahoo Finance
OPKO Health Q3 EPS Estimate Reduced by Barrington Research - MarketBeat
Phillip Frost's Significant Investment in Opko Health: A Bold Move - AInvest
Opko Health’s CEO Makes a Bold Move with Massive Stock Purchase! - TipRanks
Quote - OPKO Health, Inc.
Entera Bio Beats Q2 EPS Estimates - The Motley Fool
Entera Bio Announces Second Quarter 2025 Financial Results and Business Updates - GlobeNewswire
Opko Health (OPK) Q2 Revenue Falls 14% - AOL.com
OPKO Health (OPK) Q2 2025 Earnings Call Transcript - AOL.com
OPKO Health, Inc. (NASDAQ:OPK) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
OPKO Health (NASDAQ:OPK) Sets New 52-Week Low on Disappointing Earnings - MarketBeat
Acromegaly Pipeline 2025: Key Companies, MOA, ROA, and Clinical - openPR.com
Opko Health (OPK) Reports Fiscal Q2 2025 Results - Insider Monkey
Optimistic Growth Prospects for OPKO Health: Buy Rating with 89% Upside Potential - TipRanks
Can OPKO Health Inc. Outperform Peers After Recent PullbackAccurate Technical Trend Reversal Picks Detected - metal.it
What analysts say about OPKO Health Inc. stockFree Stock Index Interpretation - Jammu Links News
What is the dividend policy of OPKO Health Inc. stockInvest confidently with data-backed picks - Jammu Links News
OPKO Health Inc. Stock Analysis and ForecastUnrivaled growth potential - Jammu Links News
What drives OPKO Health Inc. stock priceBuild wealth steadily with smart stock selection - Jammu Links News
What makes OPKO Health Inc. stock price move sharplyOutstanding investment returns - Jammu Links News
What is OPKO Health Inc. company’s growth strategyMaximize gains with professional stock picks - Jammu Links News
What are the latest earnings results for OPKO Health Inc.Achieve breakthrough performance with smart picks - Jammu Links News
Is OPKO Health Inc. a growth stock or a value stockUnlock exclusive stock market forecasts - Jammu Links News
Why is OPKO Health Inc. stock attracting strong analyst attentionSuperior stock growth - Jammu Links News
How many analysts rate OPKO Health Inc. as a “Buy”Phenomenal wealth increase - Jammu Links News
Is it the right time to buy OPKO Health Inc. stockBuild a diversified portfolio for risk mitigation - Jammu Links News
OPKO Health (OPK.O) Plummets 7% Amid Oversold RSI and Weak Sector Sentiment - AInvest
What is the risk reward ratio of investing in OPKO Health Inc. stockGet exclusive market insights for better trading - Jammu Links News
What institutional investors are buying OPKO Health Inc. stockMaximize portfolio value with smart investment plans - Jammu Links News
What are OPKO Health Inc. company’s key revenue driversGet alerts on top growth stocks daily - Jammu Links News
OPK Stock Slips Following Q2 Earnings Miss, Gross Margin Expands - MSN
OPKO Health Second Quarter 2025 Earnings: Misses Expectations - Yahoo Finance
GSA Capital Partners LLP Boosts Stock Position in OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat
OPKO Health (OPK.O) Plunges 9.77%: What's Behind the Sharp Intraday Drop? - AInvest
OPKO Health's Strategic Asset Sale to Labcorp: A Financial Boost and Strong Analyst Expectations - AInvest
OPKO Health outlines $640M–$660M 2025 revenue target as BioReference sale and pipeline advances drive profitability push - MSN
OPKO Health (OPK.O) Dives 9.28%—What’s Behind the Sharp Intraday Drop? - AInvest
Opko Health stock hits 52-week low at 1.21 USD By Investing.com - Investing.com South Africa
Opko Health stock hits 52-week low at 1.21 USD - Investing.com
Opko Health Inc Azioni (OPK) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Opko Health Inc Azioni (OPK) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| FROST PHILLIP MD ET AL | CEO & Chairman |
Apr 10 '25 |
Buy |
1.36 |
125,000 |
169,712 |
214,001,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Apr 08 '25 |
Buy |
1.48 |
125,000 |
184,650 |
213,876,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Apr 01 '25 |
Buy |
1.65 |
100,000 |
164,850 |
213,751,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Mar 28 '25 |
Buy |
1.70 |
150,000 |
254,385 |
213,651,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Mar 17 '25 |
Buy |
1.74 |
200,000 |
347,820 |
213,501,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Feb 28 '25 |
Buy |
1.71 |
67,434 |
115,312 |
213,301,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Jan 28 '25 |
Buy |
1.47 |
47,537 |
70,060 |
213,234,014 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Jan 17 '25 |
Buy |
1.47 |
150,000 |
220,425 |
213,186,477 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Jan 15 '25 |
Buy |
1.48 |
500,000 |
740,850 |
213,036,477 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Dec 13 '24 |
Buy |
1.59 |
125,000 |
199,375 |
212,536,477 |
2.23%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):